The study of endocrine cancers and oncology focuses on tumors affecting hormone-producing glands such as the thyroid, pancreas, and adrenal glands. Malignancies like pancreatic neuroendocrine tumors and medullary thyroid carcinoma require specialized treatment approaches due to their complex interaction with hormonal regulation. Advances in molecular oncology have led to targeted therapies that inhibit abnormal signaling pathways, improving survival rates. Immunotherapy is also gaining traction as a promising approach for endocrine cancers, particularly in cases resistant to traditional chemotherapy. Early detection through biomarker screening and imaging technologies enhances treatment efficacy. Ongoing research continues to refine therapeutic options, providing hope for improved patient outcomes.
Mahir Khalil Ibrahim Jallo
Gulf Medical University, Canada
Yong Xiao Wang
Albany Medical College, United States
F Buck Willis
Belize Bible College, Belize
Sujith Rajan
NYU Long Island School of Medicine, United States
Amy Gutman
AdventHealth; Tough Love MD, United States
Paraskevi Theofilou
Hellenic Open University, Greece
Teji S Dhami
Boost your Health and Wellness, United StatesSubmit your abstract Today
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Important roles and mechanisms of novel calcium signaling in diabetes-induced vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, Belize Bible College, Belize
Title : The menopausal mind: Reframing female senescence as a neuroendocrine disorder with root cause management strategies
Amy Gutman, AdventHealth; Tough Love MD, United States
Title : Bridging the gap: Coaching patients on GLP-1s for sustainable outcomes beyond the prescription
Keith Hersey, Master Your GLP-1, United States